Glucocorticoids increase NPY gene expression in the arcuate nucleus by inhibiting mTOR signaling in rat hypothalamic organotypic cultures

Peptides

Volumn 31, Issue 1, 2010, Pages 145-149

  Shimizu, Hiroshi ^a   Arima, Hiroshi ^a   Ozawa, Yoshiharu ^a   Watanabe, Minemori ^a   Banno, Ryoichi ^a   Sugimura, Yoshihisa ^a   Ozaki, Nobuaki ^a   Nagasaki, Hiroshi ^b   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glucocorticoids; Mammalian target of rapamycin; Neuropeptide Y

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NEUROPEPTIDE Y; PROTEIN S6; RAPAMYCIN;

ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; EXPLANT; GENE EXPRESSION REGULATION; HORMONE ACTION; HYPOTHALAMUS; IN SITU HYBRIDIZATION; INHIBITION KINETICS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TISSUE LEVEL;

ANIMALS; ARCUATE NUCLEUS; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMUS; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDE Y; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIROLIMUS; TISSUE CULTURE TECHNIQUES;

MAMMALIA; RATTUS;

EID: 72749093287     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.09.036     Document Type: Article

References (31)

1. Arima H., House S.B., Gainer H., and Aguilera G. Direct stimulation of arginine vasopressin gene transcription by cAMP in parvocellular neurons of the paraventricular nucleus in organotypic cultures. Endocrinology 142 (2001) 5027-5030
2. Arima H., House S.B., Gainer H., and Aguilera G. Neuronal activity is required for the circadian rhythm of vasopressin gene transcription in the suprachiasmatic nucleus in vitro. Endocrinology 143 (2002) 4165-4171
3. Blouet C., Ono H., and Schwartz G.J. Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. Cell Metab 8 (2008) 459-467
4. Bolster D.R., Crozier S.J., Kimball S.R., and Jefferson L.S. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277 (2002) 23977-23980
5. Cota D., Matter E.K., Woods S.C., and Seeley R.J. The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. J Neurosci 28 (2008) 7202-7208
6. Cota D., Proulx K., and Seeley R.J. The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology 132 (2007) 2158-2168
7. Cota D., Proulx K., Smith K.A., Kozma S.C., Thomas G., Woods S.C., and Seeley R.J. Hypothalamic mTOR signaling regulates food intake. Science 312 (2006) 927-930
8. Dennis P.B., Jaeschke A., Saitoh M., Fowler B., Kozma S.C., and Thomas G. Mammalian TOR: a homeostatic ATP sensor. Science 294 (2001) 1102-1105
9. Goto M., Arima H., Watanabe M., Hayashi M., Banno R., Sato I., Nagasaki H., and Oiso Y. Ghrelin increases neuropeptide Y and agouti-related peptide gene expression in the arcuate nucleus in rat hypothalamic organotypic cultures. Endocrinology 147 (2006) 5102-5109
10. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Genes Dev 18 (2004) 1926-1945
11. Kuwahara S., Arima H., Banno R., Sato I., Kondo N., and Oiso Y. Regulation of vasopressin gene expression by cAMP and glucocorticoids in parvocellular neurons of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neurosci 23 (2003) 10231-10237
12. Losel R., and Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 4 (2003) 46-56
13. Lowenberg M., Verhaar A.P., van den Brink G.R., and Hommes D.W. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med 13 (2007) 158-163
14. Mori H., Inoki K., Munzberg H., Opland D., Faouzi M., Villanueva E.C., Ikenoue T., Kwiatkowski D., MacDougald O.A., Myers Jr. M.G., and Guan K.L. Critical role for hypothalamic mTOR activity in energy balance. Cell Metab 9 (2009) 362-374
15. Norman A.W., Mizwicki M.T., and Norman D.P. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3 (2004) 27-41
16. Otulakowski G., Duan W., Gandhi S., and O'Brodovich H. Steroid and oxygen effects on eIF4F complex, mTOR, and ENaC translation in fetal lung epithelia. Am J Respir Cell Mol Biol 37 (2007) 457-466
17. Polak P., and Hall M.N. mTOR and the control of whole body metabolism. Curr Opin Cell Biol 21 (2009) 209-218
18. Proulx K., Cota D., Woods S.C., and Seeley R.J. Fatty acid synthase inhibitors modulate energy balance via mammalian target of rapamycin complex 1 signaling in the central nervous system. Diabetes 57 (2008) 3231-3238
19. Reiter A.K., Bolster D.R., Crozier S.J., Kimball S.R., and Jefferson L.S. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside. Am J Physiol Endocrinol Metab 288 (2005) E980-E988
20. Ropelle E.R., Pauli J.R., Fernandes M.F., Rocco S.A., Marin R.M., Morari J., Souza K.K., Dias M.M., Gomes-Marcondes M.C., Gontijo J.A., Franchini K.G., Velloso L.A., Saad M.J., and Carvalheira J.B. A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. Diabetes 57 (2008) 594-605
21. Sandoval D., Cota D., and Seeley R.J. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu Rev Physiol 70 (2008) 513-535
22. Sarbassov D.D., Ali S.M., and Sabatini D.M. Growing roles for the mTOR pathway. Curr Opin Cell Biol 17 (2005) 596-603
23. Sato I., Arima H., Ozaki N., Watanabe M., Goto M., Hayashi M., Banno R., Nagasaki H., and Oiso Y. Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems. J Neurosci 25 (2005) 8657-8664
24. Shah O.J., Anthony J.C., Kimball S.R., and Jefferson L.S. Glucocorticoids oppose translational control by leucine in skeletal muscle. Am J Physiol Endocrinol Metab 279 (2000) E1185-E1190
25. Shah O.J., Kimball S.R., and Jefferson L.S. Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle. Am J Physiol Endocrinol Metab 278 (2000) E76-E82
26. Shimizu H., Arima H., Watanabe M., Goto M., Banno R., Sato I., Ozaki N., Nagasaki H., and Oiso Y. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology 149 (2008) 4544-4553
27. Stewart P.M. The adrenal cortex. In: Larsen P.R., Kronenberg H.M., Melmed S., and Polonsky K.S. (Eds). Williams Textbook of Endocrinology. 10th ed (2002), Saunders, Philadelphia 491-551
28. Wang H., Kubica N., Ellisen L.W., Jefferson L.S., and Kimball S.R. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J Biol Chem 281 (2006) 39128-39134
29. Woods S.C., Seeley R.J., and Cota D. Regulation of food intake through hypothalamic signaling networks involving mTOR. Annu Rev Nutr 28 (2008) 295-311
30. Wray S., Kusano K., and Gainer H. Maintenance of LHRH and oxytocin neurons in slice explants cultured in serum-free media: effects of tetrodotoxin on gene expression. Neuroendocrinology 54 (1991) 327-339
31. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 (2006) 471-484